HK1201067A1 - Sialic acid analogs - Google Patents
Sialic acid analogsInfo
- Publication number
- HK1201067A1 HK1201067A1 HK15101526.4A HK15101526A HK1201067A1 HK 1201067 A1 HK1201067 A1 HK 1201067A1 HK 15101526 A HK15101526 A HK 15101526A HK 1201067 A1 HK1201067 A1 HK 1201067A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sialic acid
- acid analogs
- analogs
- sialic
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/10—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
- C07H7/027—Keto-aldonic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161550610P | 2011-10-24 | 2011-10-24 | |
PCT/US2012/061737 WO2013063149A1 (fr) | 2011-10-24 | 2012-10-24 | Analogues de l'acide sialique |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1201067A1 true HK1201067A1 (en) | 2015-08-21 |
Family
ID=48168447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15101526.4A HK1201067A1 (en) | 2011-10-24 | 2015-02-11 | Sialic acid analogs |
Country Status (13)
Country | Link |
---|---|
US (5) | US8840926B2 (fr) |
EP (1) | EP2771348B1 (fr) |
JP (1) | JP6196224B2 (fr) |
KR (1) | KR102049214B1 (fr) |
CN (1) | CN103974965B (fr) |
AU (1) | AU2012328874B2 (fr) |
BR (1) | BR112014009760B1 (fr) |
CA (1) | CA2849114C (fr) |
ES (1) | ES2807890T3 (fr) |
HK (1) | HK1201067A1 (fr) |
IL (1) | IL231714B (fr) |
MX (1) | MX347541B (fr) |
WO (1) | WO2013063149A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9241896B2 (en) | 2008-12-19 | 2016-01-26 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
CA2805222A1 (fr) | 2010-07-13 | 2012-01-19 | Ultragenyx Pharmaceutical Inc. | Methode et formulations destinees au traitement de deficiences en acide sialique |
BR112014009760B1 (pt) | 2011-10-24 | 2022-11-29 | Ultragenyx Pharmaceutical Inc | Análogos de ácido siálico, seu uso e composição farmacêutica |
WO2013109906A2 (fr) * | 2012-01-18 | 2013-07-25 | Ultragenyx Pharmaceutical Inc. | Procédés et formulations permettant de traiter les déficiences en acide sialique |
WO2017048817A1 (fr) | 2015-09-14 | 2017-03-23 | Ultragenyx Pharmaceutical Inc. | Formes cristallines d'acide sialique ou sel ou solvate de celles-ci |
WO2024173797A1 (fr) * | 2023-02-17 | 2024-08-22 | Ultragenyx Pharmaceutical Inc. | Formes cristallines de dérivés d'acide sialique et leurs procédés d'utilisation |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6168418A (ja) | 1984-09-11 | 1986-04-08 | Kanto Ishi Pharma Co Ltd | 去痰薬 |
JPS63139193A (ja) * | 1986-11-28 | 1988-06-10 | Mect Corp | シアル酸誘導体1,7−ラクトン |
US6156544A (en) | 1993-06-09 | 2000-12-05 | Glaxo Group Limited | Process for the preparation of N-acetylneuraminic acid |
EP0820305A2 (fr) | 1995-04-04 | 1998-01-28 | Wound Healing of Oklahoma | Traitement du cancer par therapie photodynamique, combinee avec un immunoadjuvant |
US5624677A (en) | 1995-06-13 | 1997-04-29 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
CA2328085C (fr) | 1998-04-10 | 2006-08-22 | Mitsubishi Chemical Corporation | Dispersion solide contenant un derive d'acide sialique |
KR20030006721A (ko) | 2001-07-14 | 2003-01-23 | 삼성전자 주식회사 | 리소그라피 시스템 및 이를 이용한 레티클 표면의 파티클제거방법 |
DK1517710T3 (da) | 2002-06-21 | 2011-07-18 | Novo Nordisk Healthcare Ag | Pegylerede faktor VII-glycoformer |
US7238677B2 (en) | 2003-03-28 | 2007-07-03 | Kimberly-Clark Worldwide, Inc. | Prevention of urogenital infections |
WO2005056708A2 (fr) * | 2003-12-09 | 2005-06-23 | Spherics, Inc. | Polymeres bioadhesifs a fonction catechol |
EP1858489B1 (fr) | 2005-03-03 | 2019-02-27 | Mannatech, Inc. | Procédés et compositions pour une libération modifiée de suppléments nutritionnels |
US20100226855A1 (en) * | 2006-03-02 | 2010-09-09 | Spherics, Inc. | Rate-Controlled Oral Dosage Formulations |
WO2008027557A2 (fr) * | 2006-08-31 | 2008-03-06 | Spherics, Inc. | Compositions à base de topiramate et méthodes permettant d'en augmenter la biodisponibilité |
WO2008150477A2 (fr) | 2007-05-31 | 2008-12-11 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health | Mannosamine de n-acétyle en tant qu'agent thérapeutique |
CA2698108A1 (fr) | 2007-08-27 | 2009-03-12 | Massachusetts Institute Of Technology | Inhibiteurs du virus de la grippe couples a un polymere bifonctionnel |
CN102316730A (zh) | 2008-05-09 | 2012-01-11 | 天雅瑞药业有限公司 | 用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释 |
KR101116864B1 (ko) | 2008-08-01 | 2012-02-29 | 주식회사 베네비오 | 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물 |
US20100160363A1 (en) | 2008-12-19 | 2010-06-24 | Aaipharma Services Corp. | Extended-release pharmaceutical formulations |
US20100159001A1 (en) | 2008-12-19 | 2010-06-24 | Cardinal John R | Extended-Release Pharmaceutical Formulations |
US9241896B2 (en) | 2008-12-19 | 2016-01-26 | Ultragenyx Pharmaceutical Inc. | Methods and formulations for treating sialic acid deficiencies |
CN102427817B (zh) | 2009-05-15 | 2015-02-11 | 财团法人日本健康科学振兴财团 | 起因于gne蛋白质功能降低的疾病的治疗用药物、食品组合物、食品添加剂 |
CA2805222A1 (fr) | 2010-07-13 | 2012-01-19 | Ultragenyx Pharmaceutical Inc. | Methode et formulations destinees au traitement de deficiences en acide sialique |
BR112014009760B1 (pt) | 2011-10-24 | 2022-11-29 | Ultragenyx Pharmaceutical Inc | Análogos de ácido siálico, seu uso e composição farmacêutica |
WO2013109906A2 (fr) | 2012-01-18 | 2013-07-25 | Ultragenyx Pharmaceutical Inc. | Procédés et formulations permettant de traiter les déficiences en acide sialique |
JP6671305B2 (ja) | 2015-01-28 | 2020-03-25 | 協和発酵バイオ株式会社 | N−アセチルノイラミン酸アンモニウム塩・無水和物の結晶及びその製造方法 |
WO2017048817A1 (fr) | 2015-09-14 | 2017-03-23 | Ultragenyx Pharmaceutical Inc. | Formes cristallines d'acide sialique ou sel ou solvate de celles-ci |
-
2012
- 2012-10-24 BR BR112014009760-7A patent/BR112014009760B1/pt active IP Right Grant
- 2012-10-24 KR KR1020147013997A patent/KR102049214B1/ko active IP Right Grant
- 2012-10-24 CN CN201280052218.0A patent/CN103974965B/zh active Active
- 2012-10-24 MX MX2014004928A patent/MX347541B/es active IP Right Grant
- 2012-10-24 EP EP12843460.2A patent/EP2771348B1/fr active Active
- 2012-10-24 US US13/659,550 patent/US8840926B2/en active Active
- 2012-10-24 WO PCT/US2012/061737 patent/WO2013063149A1/fr active Application Filing
- 2012-10-24 AU AU2012328874A patent/AU2012328874B2/en active Active
- 2012-10-24 CA CA2849114A patent/CA2849114C/fr active Active
- 2012-10-24 ES ES12843460T patent/ES2807890T3/es active Active
- 2012-10-24 JP JP2014537380A patent/JP6196224B2/ja active Active
-
2014
- 2014-03-26 IL IL231714A patent/IL231714B/en active IP Right Grant
- 2014-08-15 US US14/461,295 patent/US9221858B2/en active Active
-
2015
- 2015-02-11 HK HK15101526.4A patent/HK1201067A1/xx unknown
- 2015-11-18 US US14/944,779 patent/US10065981B2/en active Active
-
2018
- 2018-07-31 US US16/050,343 patent/US10457701B2/en active Active
-
2019
- 2019-09-16 US US16/571,589 patent/US10889607B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2771348A4 (fr) | 2015-09-09 |
MX2014004928A (es) | 2014-11-10 |
IL231714B (en) | 2018-10-31 |
US9221858B2 (en) | 2015-12-29 |
IL231714A0 (en) | 2014-05-28 |
US10065981B2 (en) | 2018-09-04 |
BR112014009760A2 (pt) | 2017-04-18 |
US10889607B2 (en) | 2021-01-12 |
ES2807890T3 (es) | 2021-02-24 |
CA2849114C (fr) | 2020-12-15 |
US20160297846A1 (en) | 2016-10-13 |
KR102049214B1 (ko) | 2019-11-28 |
BR112014009760B1 (pt) | 2022-11-29 |
MX347541B (es) | 2017-04-28 |
US20190127409A1 (en) | 2019-05-02 |
KR20140084277A (ko) | 2014-07-04 |
CA2849114A1 (fr) | 2013-05-02 |
BR112014009760A8 (pt) | 2018-01-16 |
AU2012328874A1 (en) | 2014-04-10 |
WO2013063149A1 (fr) | 2013-05-02 |
US20130122094A1 (en) | 2013-05-16 |
AU2012328874B2 (en) | 2017-08-31 |
US20200131215A1 (en) | 2020-04-30 |
US8840926B2 (en) | 2014-09-23 |
JP2014530882A (ja) | 2014-11-20 |
EP2771348A1 (fr) | 2014-09-03 |
EP2771348B1 (fr) | 2020-05-20 |
US10457701B2 (en) | 2019-10-29 |
US20150038693A1 (en) | 2015-02-05 |
JP6196224B2 (ja) | 2017-09-13 |
CN103974965A (zh) | 2014-08-06 |
CN103974965B (zh) | 2019-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1217946A1 (zh) | 司普力西歐他汀類似物 | |
IL227754B (en) | Analogues of 4-hydroxybutyric acid with deuterium | |
ZA201401603B (en) | Novel clucagon analogues | |
ZA201309245B (en) | Novel fluoroergoline analogs | |
TWI561242B (en) | Long-acting peptide analogs | |
EP2725011A4 (fr) | Nouveau composé | |
ZA201401901B (en) | Guanidinobenzoic acid compound | |
EP2799494A4 (fr) | Solution d'acide polyamique | |
HK1201067A1 (en) | Sialic acid analogs | |
HK1203355A1 (en) | Uses of 4-desferrithiocin analogs 4- | |
GB201122305D0 (en) | Novel compound | |
GB201111742D0 (en) | Solution | |
ZA201404278B (en) | Processes for making magnolol analogs | |
HK1193407A1 (en) | Pyrrolidine-3-ylacetic acid derivative -3- | |
GB201112987D0 (en) | Novel compound | |
IL228985A0 (en) | Diazonamide analogs | |
AU2014200986B2 (en) | 4-hydroxybutyric acid analogs | |
AU2011200745B2 (en) | 4-hydroxybutyric acid analogs | |
EP2799424A4 (fr) | Dérivé d'acide 2-fluorophénylpropionique | |
GB201105988D0 (en) | Acid formation | |
GB201116456D0 (en) | Improvements relating to foorwear |